Venova Technologies Awarded $2.23M SBIR Phase II Grant From NIH For Novel Contraceptive Device
Award accelerates preclinical development of the company’s cervical barrier device toward first-in-human clinical studies CAMBRIDGE, Mass.–(BUSINESS WIRE)–Venova Technologies, Inc., a women-led startup developing a novel long-acting, hormone-free and copper-free female birth control device, has been…